Healthcare company Johnson & Johnson introduced Thursday that it’s going to now not globally produce or distribute its talcum powder.
The corporate will as an alternative produce a corn starch powder starting in 2023. Its talcum product hasn’t been on the market in the US or Canada since 2020, whereas its corn starch powder has already hit the market in some international locations.
“Our place on the security of our beauty talc stays unchanged,” Johnson & Johnson stated in a press release. “We stand firmly behind the a long time of impartial scientific evaluation by medical specialists world wide that confirms talc-based JOHNSON’S® Child Powder is secure, doesn’t comprise asbestos, and doesn’t trigger most cancers.”
BABY FORMULA SHORTAGE IS EXTENDING INTO LATE SUMMER
A shareholder proposal to discontinue the talcum powder failed in April. The proposal got here after the corporate misplaced $3.5 billion in numerous courtroom losses and settlements wherein complainants claimed they developed cancers from the talcum product.
In 2021, Johnson & Johnson began a subsidiary referred to as LTL Administration to tackle the authorized troubles surrounding its talcum product, which in the end filed for chapter.
Inner firm information and trial testimonies proved that from no less than 1971 to the early 2000s, J&J’s uncooked and completed talc powders sometimes examined constructive for small quantities of asbestos, based on experiences in 2018.